13F filing recap · Q4 2025
What did Sound Shore Management buy in Q4 2025?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Sound Shore account, including accounts that belong to no fund below.
Stock value
$3.14B
Positions
37
Estimated turnover
37.4%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Sound Shore Management opened new positions in Salesforce, Qxo, and BP, while exiting Hologic, International Paper, PayPal, and Perrigo entirely. The firm substantially increased its stakes in Regeneron Pharmaceuticals, Public Service Enterprise Group, and Kyndryl Holdings. It trimmed Teva Pharmaceutical, Citigroup, Capital One, Bank of America, General Motors, Coterra Energy, Applied Materials, and Huntington Ingalls, among others, and sharply reduced Warner Bros. Discovery.